Detalhe da pesquisa
1.
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
Cell
; 174(3): 758-769.e9, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30033370
2.
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
Cell
; 175(3): 889, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30340047
3.
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(3): 140-150, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626801
4.
Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol.
Future Oncol
; 20(12): 727-738, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488039
5.
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
Lancet Oncol
; 24(10): e415-e423, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37797647
6.
Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.
Prostate
; 83(10): 912-921, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071764
7.
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Cancer
; 129(14): 2169-2178, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060201
8.
Poly(adenosine diphosphate-ribose) polymerase inhibitor combinations in first-line metastatic castrate-resistant prostate cancer setting: a systematic review and meta-analysis.
BJU Int
; 132(6): 619-630, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461140
9.
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(10): 1067-1096, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856213
10.
Association of PSA kinetics after testosterone recovery with subsequent recurrence: secondary analysis of a phase III randomized controlled trial.
World J Urol
; 41(12): 3905-3911, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792009
11.
Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption.
World J Urol
; 41(12): 3877-3887, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851053
12.
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.
Proc Natl Acad Sci U S A
; 117(22): 12315-12323, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424106
13.
Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN): a randomized phase II study protocol.
Rep Pract Oncol Radiother
; 28(3): 379-388, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795393
14.
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.
Lancet Oncol
; 23(2): 304-316, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051385
15.
Pan-cancer analysis of prognostic metastatic phenotypes.
Int J Cancer
; 150(1): 132-141, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34287840
16.
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Prostate
; 82 Suppl 1: S73-S85, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657158
17.
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results.
Cancer
; 128(7): 1513-1522, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985771
18.
Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate Cancer.
J Urol
; 207(3): 581-591, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694160
19.
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.
J Urol
; 207(1): 127-136, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433304
20.
Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.
BMC Cancer
; 22(1): 494, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513774